Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Neel Hammond"'
Autor:
E. David Crawford, Mario A. Eisenberger, Burton M. Needles, Neel Hammond, Thomas E. Seay, Robert C. Flanigan, Danika Lew, Louis E. Schroder
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 6:145-148
Twenty-two eligible patients with advanced renal carcinoma were treated with suramin utilizing a fixed dose regimen. Therapy was reasonably well tolerated with 3 of 22 patients (14%) developing grade 4 toxicity and 11 of 22 patients (50%) having a ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b17c8b4bf14db02d3097d5ce8074664f
https://doi.org/10.1016/s1078-1439(00)00126-5
https://doi.org/10.1016/s1078-1439(00)00126-5
Autor:
Glenn Mills, Joseph M. Unger, Gary C. Doolittle, Lawrence E. Flaherty, Vernon K. Sondak, Catherine E Klein, Robert Chapman, Robert P. Whitehead, Neel Hammond, Eric H. Kraut
Publikováno v:
Investigational new drugs. 20(1)
Malignant melanoma is rapidly increasing in the United States. Metastatic disease responds poorly to currently available chemotherapy. Pyrazine diazohydroxide (PZDH) is a new agent inhibiting DNA synthesis that is active in mouse tumor models and hum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3425681ebf569585ec8396d13631a7f3
https://pubmed.ncbi.nlm.nih.gov/12003185
https://pubmed.ncbi.nlm.nih.gov/12003185
Autor:
Neel Hammond, E. David Crawford, Eric J. Small, Danika Lew, James A. Eastham, Daniel P. Petrylak, Bruce G. Redman, Howard M. Gross
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 18(13)
PURPOSE: The combination of paclitaxel and carboplatin for the treatment of advanced transitional-cell carcinoma (TCC) of the urothelium has promising activity and acceptable toxicity. The purpose of this trial was to evaluate the efficacy of this re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::390b20fbfe17d32ed13be86eedd60a17
https://pubmed.ncbi.nlm.nih.gov/10893284
https://pubmed.ncbi.nlm.nih.gov/10893284
Publikováno v:
Cancer. 41:138-142
Technetium 99m phosphate-complex bone scans were performed in 43 women within two months of mastectomy for stage I (1 patient), stage II (28 patients), and stage III (14 patients) breast cancer. Twelve (28%) initial bone scans were interpreted as eit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::87b35db3401019548ab6c898b96ec33a
https://doi.org/10.1002/1097-0142(197801)41:1<138::aid-cncr2820410122>3.0.co
https://doi.org/10.1002/1097-0142(197801)41:1<138::aid-cncr2820410122>3.0.co
Autor:
Frederick R. Ahmann, Thomas E. Moon, Stephen E. Jones, Thomas P. Miller, Brian G.M. Durie, Neel Hammond
Publikováno v:
Cancer. 56:730-737
Combined chemohormonal therapy is an attractive therapeutic strategy for the treatment of Stage IV breast cancer. Between 1977 and 1979, the authors evaluated a new chemohormonal therapy program in 63 evaluable women with advanced breast cancer who p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68f2bd922526458e6dadcbe37f549ad1
https://doi.org/10.1002/1097-0142(19850815)56:4<730::aid-cncr2820560405>3.0.co
https://doi.org/10.1002/1097-0142(19850815)56:4<730::aid-cncr2820560405>3.0.co
Autor:
Robert B. Livingston, Susan F. Schulman, Brian R. Griffin, Carol J. Fabian, Bill L. Tranum, Ronald S. Goldberg, Henry E. Hynes, Saul E. Rivkin, Neel Hammond
Publikováno v:
Cancer. 59:1249-1254
Seventy patients with poor prognosis, metastatic breast cancer were treated with FUVAC induction chemotherapy (5-fluorouracil, vinblastine, Adriamycin [doxorubicin] and cyclophosphamide). Consolidation therapy was given to 30 of 48 responders (63%),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fbba22a71940af7a1a2a996794951df3
https://doi.org/10.1002/1097-0142(19870401)59:7<1249::aid-cncr2820590703>3.0.co
https://doi.org/10.1002/1097-0142(19870401)59:7<1249::aid-cncr2820590703>3.0.co
Publikováno v:
Cancer treatment reviews. 12
The Southwest Oncology Group has carried out a phase I clinical trial of carboplatin plus cyclophosphamide and iproplatin plus cyclophosphamide in 20 patients with stages III and IV ovarian cancer prior to initiating a phase III trial to compare thes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4288967045de174fa76e4839b634cac8
https://pubmed.ncbi.nlm.nih.gov/3910225
https://pubmed.ncbi.nlm.nih.gov/3910225
Publikováno v:
Cancer Genetics and Cytogenetics. 14:371
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff8ccab97e08c41c13a7926f8e675560
https://doi.org/10.1016/0165-4608(85)90203-1
https://doi.org/10.1016/0165-4608(85)90203-1